Plasma somatomedins in children with hyperinsulinism

Area of Science:

• Pediatric Endocrinology
• Metabolic Disorders
• Growth Factor Research

Background:

• Hyperinsulinism is suspected to stimulate somatomedin (SM) production.
• Investigating the link between endogenous insulin and SM levels is crucial for understanding growth regulation.

Purpose of the Study:

• To determine if excessive endogenous insulin secretion in children with hyperinsulinism and hypoglycemia affects plasma levels of somatomedin C/insulin-like growth factor-I (SMC/IGF-I) and IGF-II.
• To explore the relationship between hyperinsulinism, hypoglycemia, and growth factor concentrations.

Main Methods:

• Studied seven children with severe fasting hypoglycemia and documented hyperinsulinism.
• Measured plasma concentrations of SMC/IGF-I and IGF-II.
• Analyzed correlations between growth factors, body weight, and length.

Main Results:

• Plasma SMC/IGF-I and IGF-II levels were not significantly different in children with hyperinsulinism compared to normal children.
• SMC/IGF-I and IGF-II showed an inverse correlation with each other.
• SMC/IGF-I positively correlated with body weight, while IGF-II inversely correlated with body weight and length.

Conclusions:

• In children with normal growth hormone (GH) secretion, hyperinsulinism causing severe hypoglycemia does not elevate plasma SMC/IGF-I or IGF-II.
• These findings challenge the hypothesis that hyperinsulinism directly stimulates SM synthesis in vivo under these conditions.